contact us
site map
Juvaris In the News
Juvaris Technology
Juvaris BioTherapeutics Announces License to Colby Pharmaceutical Company for JVRS-100 and CLDC (Cationic Lipid-DNA Complex) Platform for Human Health
Juvaris BioTherapeutics Announces Publication of Preclinical Anti-Leukemic Effects of JVRS-100 Immunotherapy
Juvaris BioTherapeutics Completes Second Close on $25 million Series B Financing
More »
Terms of Use
|
Legal
|
Site Users Guide
© 2014 Juvaris BioTherapeutics.